Activation of c-Jun-N-terminal kinase in a rat model of intracerebral hemorrhage: The role of iron

Neuroscience Research

Volumn 63, Issue 2, 2009, Pages 100-105

  Wan, Shu ^a,b   Zhan, Renya ^a   Zheng, Shusen ^a   Hua, Ya ^b   Xi, Guohua ^b  

^a Affiliated Hospital   (China)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

c Jun N terminal kinase; Cerebral hemorrhage; Deferoxamine; Iron

Indexed keywords

DEFEROXAMINE; IRON; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN HEMORRHAGE; CONTROLLED STUDY; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CEREBRAL HEMORRHAGE; DEFEROXAMINE; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FUNCTIONAL LATERALITY; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IRON; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MOTOR ACTIVITY; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; SIDEROPHORES; TIME FACTORS;

EID: 58149518482     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2008.10.013     Document Type: Article

References (33)

1. Gao Y., Signore A.P., Yin W., Cao G., Yin X.M., Sun F., Luo Y., Graham S.H., and Chen J. Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway. J. Cereb. Blood Flow Metab. 25 (2005) 694-712
2. Guo Y., and Regan R.F. Delayed therapy of hemoglobin neurotoxicity. Acad. Emerg. Med. 8 (2001) 510
3. Hua Y., Keep R., Hoff J., and Xi G. Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke 38 (2007) 759-762
4. Hua Y., Nakamura T., Keep R., Wu J., Schallert T., Hoff J., and Xi G. Long-term effects of experimental intracerebral hemorrhage: the role of iron. J. Neurosurg. 104 (2006) 305-312
5. Hua Y., Schallert T., Keep R.F., Wu J., Hoff J.T., and Xi G. Behavioral tests after intracerebral hemorrhage in the rat. Stroke 33 (2002) 2478-2484
6. Hua Y., Xi G., Keep R.F., Wu J., Jiang Y., and Hoff J.T. Plasminogen activator inhibitor-1 induction after experimental intracerebral hemorrhage. J. Cereb. Blood Flow Metab. 22 (2002) 55-61
7. Huang F., Xi G., Keep R.F., Hua Y., Nemoianu A., and Hoff J.T. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J. Neurosurg. 96 (2002) 287-293
8. Hurn P.D., Koehler R.C., Blizzard K.K., and Traystman R.J. Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. Stroke 26 (1995) 688-694 (discussion 694-695)
9. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81 (2001) 807-869
10. Liachenko S., Tang P., and Xu Y. Deferoxamine improves early postresuscitation reperfusion after prolonged cardiac arrest in rats. J. Cereb. Blood Flow Metab. 23 (2003) 574-581
11. Manning A.M., and Davis R.J. Targeting JNK for therapeutic benefit: from junk to gold?. Nat. Rev. Drug Discov. 2 (2003) 554-565
12. Maroney A.C., Glicksman M.A., Basma A.N., Walton K.M., Knight Jr. E., Murphy C.A., Bartlett B.A., Finn J.P., Angeles T., Matsuda Y., Neff N.T., and Dionne C.A. Motoneuron apoptosis is blocked by CEP-1347 (KT 7515): a novel inhibitor of the JNK signaling pathway. J. Neurosci. 18 (1998) 104-111
13. Martin J.H., Mohit A.A., and Miller C.A. Developmental expression in the mouse nervous system of the p493F12 SAP kinase. Brain Res. Mol. Brain Res. 35 (1996) 47-57
14. Nakamura T., Keep R., Hua Y., Schallert T., Hoff J., and Xi G. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J. Neurosurg. 100 (2004) 672-678
15. Nakamura T., Keep R.F., Hua Y., Hoff J.T., and Xi G. Oxidative DNA injury after experimental intracerebral hemorrhage. Brain Res. 1039 (2005) 30-36
16. Nakamura T., Xi G., Park J.W., Hua Y., Hoff J.T., and Keep R.F. Holo-transferrin and thrombin can interact to cause brain damage. Stroke 36 (2005) 348-352
17. Nilsson U.A., Bassen M., Savman K., and Kjellmer I. A simple and rapid method for the determination of "free" iron in biological fluids. Free Radic. Res. 36 (2002) 677-684
18. Ohnishi M., Katsuki H., Fujimoto S., Takagi M., Kume T., and Akaike A. Involvement of thrombin and mitogen-activated protein kinase pathways in hemorrhagic brain injury. Exp. Neurol. 206 (2007) 43-52
19. Okuno S., Saito A., Hayashi T., and Chan P.H. The c-Jun N-terminal protein kinase signaling pathway mediates Bax activation and subsequent neuronal apoptosis through interaction with Bim after transient focal cerebral ischemia. J. Neurosci. 24 (2004) 7879-7887
20. Otterbein L.E., Soares M.P., Yamashita K., and Bach F.H. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24 (2003) 449-455
21. Palmer C., Roberts R.L., and Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke 25 (1994) 1039-1045
22. Prass K., Ruscher K., Karsch M., Isaev N., Megow D., Priller J., Scharff A., Dirnagl U., and Meisel A. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab. 22 (2002) 520-525
23. Regan R.F., and Panter S.S. Neurotoxicity of hemoglobin in cortical cell culture. Neurosci. Lett. 153 (1993) 219-222
24. Sadrzadeh S.M., Anderson D.K., Panter S.S., Hallaway P.E., and Eaton J.W. Hemoglobin potentiates central nervous system damage. J. Clin. Invest. 79 (1987) 662-664
25. Waetzig V., Czeloth K., Hidding U., Mielke K., Kanzow M., Brecht S., Goetz M., Lucius R., Herdegen T., and Hanisch U.K. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 50 (2005) 235-246
26. Wagner K.R., Sharp F.R., Ardizzone T.D., Lu A., and Clark J.F. Heme and iron metabolism: role in cerebral hemorrhage. J. Cereb. Blood Flow Metab. 23 (2003) 629-652
27. Wu J., Hua Y., Keep R.F., Nakamura T., Hoff J.T., and Xi G. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 34 (2003) 2964-2969
28. Wu J., Hua Y., Keep R.F., Schallert T., Hoff J.T., and Xi G. Oxidative brain injury from extravasated erythrocytes after intracerebral hemorrhage. Brain Res. 953 (2002) 45-52
29. Xi G., Keep R., and Hoff J. Mechanisms of brain injury after intracerebral hemorrhage. Lancet Neurol. 5 (2006) 53-63
30. Xi G., Keep R.F., and Hoff J.T. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J. Neurosurg. 89 (1998) 991-996
31. Xi G., Keep R.F., Hua Y., Xiang J.M., and Hoff J.T. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30 (1999) 1247-1255
32. Xi G., Reiser G., and Keep R.F. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective?. J. Neurochem. 84 (2003) 3-9
33. Yatsushige H., Yamaguchi M., Zhou C., Calvert J.W., and Zhang J.H. Role of c-Jun N-terminal kinase in cerebral vasospasm after experimental subarachnoid hemorrhage. Stroke 36 (2005) 1538-1543